The Guardian is running a major editorial series called The Pain That Can’t be Seen, which takes an in-depth look at the growing health issue of chronic pain and how the pandemic might have exacerbated it given musculoskeletal pain is a common complaint of those who have had Covid-19. “Sufferers of chronic pain have long …
The Guardian’s week-long series on chronic pain and long Covid Read More »
Many of the world’s most well-known phrases about pain imply that it is helpful to experience it, that pain provides lessons for life or shows that we’ve made an effort, offering a point of comparison for our eventual happiness. After all, what doesn’t kill you makes you stronger, right? While it’s true that difficulties do …
Newsroom, an independent, New Zealand-based news and current affairs site interviewed Richard Little this week and were able to get a first hand experience of how Axon is used to treat chronic pain. Business Reporter, Anuja Nadkarni met with Richard at Exsurgo to discuss how EEG feedback works, talk about the recent success of the …
Newsroom covers how Exsurgo are treating chronic pain with brain training Read More »
New Zealand neuroscience company Exsurgo has appointed experienced senior engineering executive, Jiva Muthu as Chief Operating Officer. Muthu joins Exsurgo from Rakon – one of the world’s largest manufacturers of frequency control products and timing solutions – and has 18 years’ experience in the medical devices industry with Fisher & Paykel Healthcare, Rex Bionics and …
Neuroscience company Exsurgo announces Jiva Muthu as COO Read More »
At Exsurgo, our vision is to unlock the power of neuroscience to ease suffering and enhance human potential. We’re on a mission to transform the way the world treats neurological problems with effective, accessible and non-pharmaceutical solutions that harness the latest in science, technology, engineering and big data. It’s a lofty goal, but a recent …
Making [brain] waves in the UK by Richard Little, CEO, Exsurgo Read More »
A recent UK study has confirmed the exciting potential of a breakthrough treatment for chronic pain management developed by neuroscience company, Exsurgo. Chronic pain (defined as pain that persists for longer than three months) affects up to 1 in 5 people around the world and is a massive burden on healthcare systems and economies. Chronic …
Newshub, one of New Zealand’s biggest news services, has reported on the potential of Exsurgo’s Axon technology to help treat chronic pain and shared the results of a proof-of-concept trial in the UK. As Laura Tupou’s story said: The answer to chronic pain management could be to retrain your brain. A Kiwi company has designed …
In a new study, researchers have found that the prevalence of chronic pain is increasing for all demographics of U.S. adults. The research, which appears in the journal Demography, highlights that the prevalence of chronic pain has increased the most for people from lower socioeconomic backgrounds. “We looked at the data from every available perspective, including …
More and more US adults have chronic pain, new study shows Read More »
The Guardian has reported on a significant change to guidelines for pain treatment from the UK’s National Institute for Health and Care Excellence, which say that doctors “should advise sufferers to use physical and psychological therapies rather than analgesics to manage their pain”. There is “little or no evidence†that treating the condition with painkillers makes any difference to the person’s …
Exsurgo has appointed experienced financial executive John Emson as its first Chief Financial Officer. Emson, who has spent over 30 years in finance and M&A across the technology, manufacturing, health and education sectors, has been working closely with Exsurgo co-founder Richard Little as an advisor to the company since last year. Exsurgo is developing technologies …
